ArticleBladder cancer (Amsterdam, Netherlands)2022

MHC I Expression Predicts Response to Checkpoint Inhibitors in Metastatic Urothelial Carcinoma but Lacks Prognostic Value in Localized Disease.

Julia Slotta-Huspenina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.